261 related articles for article (PubMed ID: 25297745)
21. Sustained molecular remission in advanced acute promyelocytic leukemia with combined pulsed retinoic acid and arsenic trioxide. Clinical evidence of synergistic effect and real-time quantification of minimal residual disease.
Visani G; Piccaluga PP; Martinelli G; Rossi M; Malagola M; Baccarani M
Haematologica; 2003 Apr; 88(4):ELT15. PubMed ID: 12681992
[No Abstract] [Full Text] [Related]
22. [Successful treatment of acute promyelocytic leukemia complicated with autoimmune hepatitis-induced portal hypertension with all-trans retinoic acid].
Ushiki T; Nikkuni K; Yoshida C; Shibasaki Y; Ishikawa T; Masuko M; Takai K
Rinsho Ketsueki; 2012 Jan; 53(1):97-104. PubMed ID: 22374532
[TBL] [Abstract][Full Text] [Related]
23. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
Rashidi A; Fisher SI
Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
[No Abstract] [Full Text] [Related]
24. Updates on the treatment of acute promyelocytic leukemia.
Tallman MS
Clin Adv Hematol Oncol; 2010 Feb; 8(2):89-90. PubMed ID: 20386527
[No Abstract] [Full Text] [Related]
25. Persistence of retinoic acid sensitivity in relapsed acute promyelocytic leukemia with extramedullary involvement.
Thomas X; Fiere D; Archimbaud E
Leukemia; 1994 Mar; 8(3):520-1. PubMed ID: 8127158
[No Abstract] [Full Text] [Related]
26. Extramedullary disease in APL: a real phenomenon to contend with or not?
Ganzel C; Douer D
Best Pract Res Clin Haematol; 2014 Mar; 27(1):63-8. PubMed ID: 24907018
[TBL] [Abstract][Full Text] [Related]
27. Acute promyelocytic leukemia can be treated successfully without cytotoxic chemotherapy.
Ravandi F
Oncology (Williston Park); 2011 Jul; 25(8):741-3. PubMed ID: 21874836
[No Abstract] [Full Text] [Related]
28. [Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
Miyawaki S
Rinsho Ketsueki; 2014 Jan; 55(1):31-41. PubMed ID: 24492035
[No Abstract] [Full Text] [Related]
29. Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.
Huang H; Qin Y; Xu R; You X; Teng R; Yang L; Xu M; Liu H
Leuk Res; 2012 Jul; 36(7):841-5. PubMed ID: 22534100
[TBL] [Abstract][Full Text] [Related]
30. Lessons taught by acute promyelocytic leukemia cure.
de Thé H
Lancet; 2015 Jul; 386(9990):247-8. PubMed ID: 26194524
[No Abstract] [Full Text] [Related]
31. Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: a TRAnsition to targeted therapies.
Arteaga MF; Mikesch JH; Fung TK; So CW
Br J Cancer; 2015 Feb; 112(3):413-8. PubMed ID: 25247321
[TBL] [Abstract][Full Text] [Related]
32. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
[TBL] [Abstract][Full Text] [Related]
33. The PRKAR1A gene is fused to RARA in a new variant acute promyelocytic leukemia.
Catalano A; Dawson MA; Somana K; Opat S; Schwarer A; Campbell LJ; Iland H
Blood; 2007 Dec; 110(12):4073-6. PubMed ID: 17712046
[TBL] [Abstract][Full Text] [Related]
34. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
35. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ
J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathology of acute promyelocytic leukemia.
Chang KS
Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
[No Abstract] [Full Text] [Related]
37. Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.
Iland HJ; Wei A; Seymour JF
Best Pract Res Clin Haematol; 2014 Mar; 27(1):39-52. PubMed ID: 24907016
[TBL] [Abstract][Full Text] [Related]
38. High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia.
Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
Leuk Res; 2013 Jan; 37(1):37-42. PubMed ID: 23017225
[TBL] [Abstract][Full Text] [Related]
39. Current treatment of acute promyelocytic leukemia.
Lo Coco F; Ammatuna E; Sanz MA
Haematologica; 2007 Mar; 92(3):289-91. PubMed ID: 17339175
[No Abstract] [Full Text] [Related]
40. Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.
Au WY; Kumana CR; Kou M; Mak R; Chan GC; Lam CW; Kwong YL
Blood; 2003 Jul; 102(1):407-8. PubMed ID: 12814916
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
